Akosua Mireku

Caption: Experts at the LSX World Congress 2025 discussed the potential challenges and benefits associated with the EU AI Act. Credit: Leestat via Getty Images. The EU Artificial Intelligence (AI) Act may protect citizens, but some experts in the life […]

Ahead of rare disease day, experts discussed the barriers to gene therapy development for the inborn errors of metabolism. Credit: itakdalee via Shutterstock In recent years, major progress has been made in the development of gene therapies for rare diseases.

On 12 January, the EMA implemented the revamped EU HTA regulation for the assessment of cancer therapies and cell and gene therapies. Credit: Vepar5 via Getty Images Amid a wave of healthcare regulatory changes in the EU, an update on

Neumora’s share price plummeted after the company shared news on a Phase III trial failure for its lead candidate. Credit: Ground Picture via Shutterstock Neumora Therapeutics saw a drop of more than 80% in its share price following the announcement

RFK Jr’s appointment as HHS head is likely to shake up flu vaccine regulation, say experts. Credit: The Washington Post via Getty Images As countries in the Northern hemisphere deal with the flu season, experts say regulation surrounding flu vaccines

Credit: Ulrich Baumgarten via Getty Images. Dr Jonathan Weber shared insights on the HIV prophylactic landscape, citing the transformative impact of PrEP therapies. Research activity in the human immunodeficiency viruses space (HIV) is pivoting towards pre-exposure prophylaxis (PrEP) therapies as

At the Outsourcing in Clinical Trials Conference in New England, experts shared insights on how the US clinical trial and pharmaceutical space could keep up with evolving challenges. Credit: OsakaWayne Studios via Getty Images. As the US enters a new

As biosimilars enter the psoriasis market, key opinion leaders anticipate a shift in patient preference from IL-23 therapies to IL-17 therapies due to pricing and access, amidst a wider change driven by the Inflation Reduction Act. Tanja Ivanova via Getty

In an exclusive interview with Pharmaceutical Technology, Dr Kenneth Getz attributed the wave of pharma layoffs to patent cliffs and uncertainty due to the upcoming US election. Credit: Hryshchyshen Serhii via Shutterstock. Geopolitical events and economic fluctuations have impacted the

At the Outsourcing in Clinical Trials Conference in New England, the CBP warned attendees of the common legal pitfalls researchers make in transporting material for clinical research. Credit: Jonathan Weiss via Shutterstock. The incorrect transport of biological materials opens the